HUP9802716A2 - Pharmaceutical composition of analgesic activity - Google Patents

Pharmaceutical composition of analgesic activity

Info

Publication number
HUP9802716A2
HUP9802716A2 HU9802716A HUP9802716A HUP9802716A2 HU P9802716 A2 HUP9802716 A2 HU P9802716A2 HU 9802716 A HU9802716 A HU 9802716A HU P9802716 A HUP9802716 A HU P9802716A HU P9802716 A2 HUP9802716 A2 HU P9802716A2
Authority
HU
Hungary
Prior art keywords
pharmaceutical composition
methyl
analgesic activity
compound
xanthine
Prior art date
Application number
HU9802716A
Other languages
Hungarian (hu)
Inventor
Endre Mikus
Péter Arányi
Zsuzsanna Fürst
Kovács Attila B.
Péterné Kovács
Original Assignee
Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. filed Critical Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt.
Priority to HU9802716A priority Critical patent/HUP9802716A3/en
Publication of HU9802716D0 publication Critical patent/HU9802716D0/en
Priority to CZ20011847A priority patent/CZ20011847A3/en
Priority to EA200100581A priority patent/EA004375B1/en
Priority to PL99348631A priority patent/PL348631A1/en
Priority to EEP200100281A priority patent/EE200100281A/en
Priority to PCT/HU1999/000079 priority patent/WO2000030715A1/en
Priority to EP99957378A priority patent/EP1131135A1/en
Priority to AU15102/00A priority patent/AU1510200A/en
Priority to HU0202838A priority patent/HUP0202838A3/en
Priority to SK687-2001A priority patent/SK6872001A3/en
Priority to YU37001A priority patent/YU37001A/en
Publication of HUP9802716A2 publication Critical patent/HUP9802716A2/en
Publication of HUP9802716A3 publication Critical patent/HUP9802716A3/en
Priority to HR20010403A priority patent/HRP20010403A2/en
Priority to BG105616A priority patent/BG105616A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A találmány tárgya gyógyászati készítmény, mely hatóanyagként valamelyfájdalőmcsillapító vegyületet és valamely xantinvázas vegyületettartalmaz, ahől a fájdalőmcsillapító és xantinvázas vegyület aránya (1: 20) : 1, előnyösen 10 : 1. A találmány szerinti gyógyászatikészítmény fájdalőmcsillapító vegyületként előnyösen mőrfint,aminőphenazőnt, nőraminőphenazőnt, acetilszalicilsavat, indőmethacint,ibűprőfént, diclőphenacőt, kődeint tartalmaz. A találmány szerintigyógyászati készítmény xantinvázas vegyületként előnyösen 3-metil-xantint, teőbrőmint, vagy CH-13584-t[1H-pűrin-2,6-diőn-3,7-dihidrő-3-metil-7(5-metil-1,2,3,4-őxadiazől-3-il)- metilt tartalmaz. ŕThe subject of the invention is a medicinal preparation, which contains as an active ingredient a pain-relieving compound and a xanthine-based compound, where the ratio of the pain-relieving compound to the xanthine-based compound is (1:20): 1, preferably 10:1. contains indúmethacin, ibőpröfen, diclóphenac, ködein. The pharmaceutical composition according to the invention preferably contains 3-methylxanthine, bromine, or CH-13584-t[1H-purine-2,6-dione-3,7-dihydro-3-methyl-7(5-methyl-1, Contains 2,3,4-oxadiazol-3-yl)-methyl. ŕ

HU9802716A 1998-11-25 1998-11-25 Pharmaceutical composition of analgesic activity HUP9802716A3 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
HU9802716A HUP9802716A3 (en) 1998-11-25 1998-11-25 Pharmaceutical composition of analgesic activity
YU37001A YU37001A (en) 1998-11-25 1999-11-23 Analgesic drug combination
EP99957378A EP1131135A1 (en) 1998-11-25 1999-11-23 Composition containing an analgesic and theobromine
HU0202838A HUP0202838A3 (en) 1998-11-25 1999-11-23 Composition containing an analgesic and a xanthine or a xanthine derivative
PL99348631A PL348631A1 (en) 1998-11-25 1999-11-23 Composition containing an analgesic and a xanthine or a xanthine derivative
EEP200100281A EE200100281A (en) 1998-11-25 1999-11-23 Analgesic pharmaceutical composition
PCT/HU1999/000079 WO2000030715A1 (en) 1998-11-25 1999-11-23 Composition containing an analgesic and a xanthine or a xanthine derivative
CZ20011847A CZ20011847A3 (en) 1998-11-25 1999-11-23 Preparation containing analgesic and xanthine or xanthine derivatives
AU15102/00A AU1510200A (en) 1998-11-25 1999-11-23 Composition containing an analgesic and a xanthine or a xanthine derivative
EA200100581A EA004375B1 (en) 1998-11-25 1999-11-23 Composition containing analgetic medicaments
SK687-2001A SK6872001A3 (en) 1998-11-25 1999-11-23 Composition containing an analgesic and a xanthine or a xanthine derivative
HR20010403A HRP20010403A2 (en) 1998-11-25 2001-05-25 Composition containing an analgesic and a xanthine or a xanthine derivative
BG105616A BG105616A (en) 1998-11-25 2001-06-18 Pharmaceutical compositions of analgesic effect

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9802716A HUP9802716A3 (en) 1998-11-25 1998-11-25 Pharmaceutical composition of analgesic activity

Publications (3)

Publication Number Publication Date
HU9802716D0 HU9802716D0 (en) 1999-01-28
HUP9802716A2 true HUP9802716A2 (en) 2000-06-28
HUP9802716A3 HUP9802716A3 (en) 2000-08-28

Family

ID=89997413

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9802716A HUP9802716A3 (en) 1998-11-25 1998-11-25 Pharmaceutical composition of analgesic activity

Country Status (12)

Country Link
EP (1) EP1131135A1 (en)
AU (1) AU1510200A (en)
BG (1) BG105616A (en)
CZ (1) CZ20011847A3 (en)
EA (1) EA004375B1 (en)
EE (1) EE200100281A (en)
HR (1) HRP20010403A2 (en)
HU (1) HUP9802716A3 (en)
PL (1) PL348631A1 (en)
SK (1) SK6872001A3 (en)
WO (1) WO2000030715A1 (en)
YU (1) YU37001A (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BG65576B1 (en) * 2002-04-17 2009-01-30 ПИРИМОВА Румяна Composition of an analgesic, suitable in particular for headache and migraine
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0919893D0 (en) * 2009-11-13 2009-12-30 Biocopea Ltd Drug composition and its use in therapy
AU2015201845B2 (en) * 2009-11-13 2015-11-05 Infirst Healthcare Limited Drug combination with theobromine and its use in therapy
WO2013005226A1 (en) * 2011-07-04 2013-01-10 Zota Health Care Ltd A novel combined pharmaceutical composition containing diclofenac and methods of making and using the same
US8853189B2 (en) 2012-05-31 2014-10-07 Prima Innovations, Llc Antispasmodic 1,2-Diols and 1,2,3-triols

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986003681A1 (en) * 1984-12-26 1986-07-03 Abraham Sunshine Analgesic, anti-inflammatory and skeletal muscle relaxant compositions
AU7604094A (en) * 1993-09-07 1995-03-27 Procter & Gamble Company, The Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
GB9613457D0 (en) * 1996-06-27 1996-08-28 Procter & Gamble Pharmaceutical compositions

Also Published As

Publication number Publication date
CZ20011847A3 (en) 2002-07-17
YU37001A (en) 2004-05-12
BG105616A (en) 2002-01-31
AU1510200A (en) 2000-06-13
EE200100281A (en) 2002-08-15
PL348631A1 (en) 2002-06-03
WO2000030715A1 (en) 2000-06-02
EP1131135A1 (en) 2001-09-12
EA200100581A1 (en) 2001-12-24
SK6872001A3 (en) 2002-05-09
HU9802716D0 (en) 1999-01-28
EA004375B1 (en) 2004-04-29
HRP20010403A2 (en) 2002-06-30
HUP9802716A3 (en) 2000-08-28

Similar Documents

Publication Publication Date Title
HUP0301972A2 (en) Active substance combination containing an opioid having a fentanyl-type structure and ketamine and pharmaceutical compositions containing it
SE0001899D0 (en) New compounds
FR11C0017I2 (en) Use of spinosad or a formulation comprising spinosad
EE04800B1 (en) Oral dosage form for acid unstable active ingredient, unit dosage form, method of preparation and use, and method for oral dosage form
HUP0203176A2 (en) Solid, oral pharmaceutical composition containing simethicone
ES2178430T3 (en) USE OF GELIFICABLE PHARMACEUTICAL COMPOSITIONS IN PARODONTOLOGY.
BR0214343A (en) 11 - Beta - Hydroxy Steroid Dehydrogenase Inhibitors Type 1
SE8804629D0 (en) NEW THERAPEUTICALLY ACTIVE COMPOUNDS
MXPA02002249A (en) Palatable pharmaceutical compositions for companion animals.
ATE431149T1 (en) ANALOGUE OF BARBITURIC ACID AS THERAPEUTIC ACTIVE INGREDIENTS
NO20030897D0 (en) Process for the preparation of pharmaceutical compositions for use with wet gelatin formulations
HUP0401569A2 (en) Pharmaceutical compositions of amlodipine and atorvastatin and process for their preparation
DK1383752T3 (en) Deuterated 3-piperidinopropiophenones as well as drugs containing these compounds
UA35604C2 (en) Pharmaceutical composition possessing antidepressant activity
HUP0301390A2 (en) Oral pharmaceutical composition containing valsartan
PT1140031E (en) PHARMACEUTICAL PREPARATION OF CONTROLLED LIBERATION WITH TILIDINE MESYLATE AS AN ACTIVE SUBSTANCE
HUP9802716A2 (en) Pharmaceutical composition of analgesic activity
WO2002030467A3 (en) Pharmaceutical composition containing honey for the treatment of wounds
WO2005004915A3 (en) Compositions comprising meloxicam
HUP9802897A2 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
ATE410152T1 (en) THERAPEUTIC SYSTEM WITH AMOXICILLIN AND CLAVULANIC ACID
SE0000303D0 (en) Novel compounds
DE60302951D1 (en) Pyroglutamic acid salt of amlodipine
HUP0000997A2 (en) New medicament combination
PT1202956E (en) THERAPEUTIC AND / OR NURITIONALLY IMPROVED DERIVATIVES OF ACTIVE INGREDIENTS AND ORAL ADMINISTRATION COMPOSITIONS CONTAINING THE SAME